Paul Bishop is Chief Executive Officer of Atlantic Research Group, one of the fastest growing and most successful CROs dedicated to small and emerging biopharmaceutical concerns. Paul, with his co-founder Lyle Camblos, has led ARG to 10 years of record sales and customer growth. Prior to co-founding ARG, Paul served in various management roles at a large global CRO, where he specialized in project and functional management for small biotech projects. His professional experience includes oncological, immunological, metabolic disease and ophthalmological development programs both in project management and business development. Before that, Paul held clinical development positions and participated in academic research at the University of Virginia. Paul received his Bachelors of Arts in Biology from the University of Virginia.
When asked why he and Lyle formed Atlantic Research Group, he answers simply, “We believe that helping biopharmaceutical innovations reach the people for which they are designed, is one of the great opportunities of our time.”